<DOC>
	<DOCNO>NCT00124852</DOCNO>
	<brief_summary>The efficacy EPA-DHA supplementation assess randomize placebo-controlled trial cognitive decline early sign depression primary outcome measure .</brief_summary>
	<brief_title>The Efficacy Omega-3 Fatty Acids Maintaining Optimal Mental Health Elderly People</brief_title>
	<detailed_description>The efficacy EPA-DHA supplementation assess randomize placebo-controlled trial cognitive decline early sign depression primary outcome measure . In study 300 elderly people randomly allocate one three treatment . Two group receive fish oil capsule different dos EPA/DHA ( normal dose high dose ) third group receive placebo capsule . At start end intervention period cognitive function , occurrence depression , quality life , anthropometric value biochemical indicator measure . After completion trial workshop organize outcome propose study present representative several key area concern mental health elderly people .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Men woman Aged 65 year Informed consent sign A score &gt; 16 CESD ( Centre Epidemiological StudiesDepression Scale A score &lt; 21 point MMSE ( MiniMental State Examination ) Current recent ( &lt; 4 week ) use fish oil supplement intake 4 time fish judge fish consumption questionnaire Current use pharmacological antidepressant Current use dementia ( Alzheimer ) medication Serious liver disease Use 4 glass alcohol per day Unable participate judge responsible medical physician Allergy fish ( oil ) Swallowing problem Participation another clinical trial le 2 month start trial time</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>cognition</keyword>
	<keyword>depression</keyword>
	<keyword>elderly</keyword>
</DOC>